Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial.
<h4>Background</h4>The impact on carriage and optimal schedule for primary vaccination of older children with 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) are unknown.<h4>Methods</h4>600 Kenyan children aged 12-59 months wer...
Saved in:
| Main Authors: | Laura L Hammitt, John Ojal, Mahfudh Bashraheil, Susan C Morpeth, Angela Karani, Ahsan Habib, Dorota Borys, David Goldblatt, J Anthony G Scott |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0085459 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers.
by: Leah M Feazel, et al.
Published: (2015-01-01) -
Evaluation of statistical models of carriage to predict the impact of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Nigeria
by: Aishatu L. Adamu, et al.
Published: (2025-08-01) -
Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children.
by: Philip Ayieko, et al.
Published: (2013-01-01) -
Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial.
by: Hanna Rinta-Kokko, et al.
Published: (2022-01-01) -
Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into non-typeable Haemophilus influenza pathogenesis
by: Anthony Shadid, et al.
Published: (2024-12-01)